Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Kulik

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Gastroenterology|October 28, 2004
Living donor liver transplantation for hepatocellular carcinomaLaura Kulik, Michael Abecassis
Clinics in Liver Disease|January 9, 2003
Hepatic manifestations of pulmonary diseasesThomas J Layden, Laura Kulik
Current Opinion in Organ Transplantation|February 7, 2018
Hepatocellular carcinoma in the wait-listed patient with hepatitis C virusStacey B Prenner, Laura Kulik
Gastroenterology|October 28, 2018
Epidemiology and Management of Hepatocellular CarcinomaLaura Kulik, Hashem B El-Serag
Clinics in Liver Disease|April 30, 2015
Systemic therapy of hepatocellular carcinoma: current and promisingAparna Kalyan, Halla Nimeiri, Laura Kulik
The American Journal of Gastroenterology|October 10, 2020
Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges AheadAnjana Pillai, Joseph Ahn, Laura Kulik
Clinics in Liver Disease|October 5, 2020
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?Anjana A Pillai, Meera Ramanathan, Laura Kulik
Journal of Hepatology|March 2, 2021
Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settingsMichelle T Martin, Sonalie Patel, Laura Kulik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2024
Integrating immune check inhibitors in liver transplantation for hepatocellular carcinoma: The right time and the right patientGrainne O'Kane, Parissa Tabrizian, Laia Aceituno, et al.
Annals of Hepatology|August 26, 2014
Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomesKarlyn Martin, Leila Kia, Neehar D Parikh, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Gastroenterology|October 28, 2004
Living donor liver transplantation for hepatocellular carcinomaLaura Kulik, Michael Abecassis
Clinics in Liver Disease|January 9, 2003
Hepatic manifestations of pulmonary diseasesThomas J Layden, Laura Kulik
Current Opinion in Organ Transplantation|February 7, 2018
Hepatocellular carcinoma in the wait-listed patient with hepatitis C virusStacey B Prenner, Laura Kulik
Gastroenterology|October 28, 2018
Epidemiology and Management of Hepatocellular CarcinomaLaura Kulik, Hashem B El-Serag
Clinics in Liver Disease|April 30, 2015
Systemic therapy of hepatocellular carcinoma: current and promisingAparna Kalyan, Halla Nimeiri, Laura Kulik
The American Journal of Gastroenterology|October 10, 2020
Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges AheadAnjana Pillai, Joseph Ahn, Laura Kulik
Clinics in Liver Disease|October 5, 2020
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?Anjana A Pillai, Meera Ramanathan, Laura Kulik
Journal of Hepatology|March 2, 2021
Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settingsMichelle T Martin, Sonalie Patel, Laura Kulik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2024
Integrating immune check inhibitors in liver transplantation for hepatocellular carcinoma: The right time and the right patientGrainne O'Kane, Parissa Tabrizian, Laia Aceituno, et al.
Annals of Hepatology|August 26, 2014
Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomesKarlyn Martin, Leila Kia, Neehar D Parikh, et al.
Pageof 12